Genetic variations, such as single nucleotide polymorphisms (SNPs), can lead to differences in drug target expression or function among individuals. Such variations can influence the susceptibility to adverse drug reactions. For example, polymorphisms in enzymes like CYP450 can affect drug metabolism, altering the concentration of the drug and its metabolites, thereby impacting toxicity.
